XML 43 R32.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2020
Fair Value Disclosures [Abstract]  
Schedule of other financial instruments in carrying values and fair values
Our other material financial instruments had the following carrying values and fair values as of the dates shown (dollars in thousands):
September 30, 2020December 31, 2019
LevelCarrying ValueFair ValueCarrying ValueFair Value
Senior Unsecured Notes, net (a) (b) (c)
2$4,513,243 $4,856,950 $4,390,189 $4,682,432 
Non-recourse mortgages, net (a) (b) (d)
31,234,197 1,240,191 1,462,487 1,487,892 
__________
(a)The carrying value of Senior Unsecured Notes, net (Note 10) includes unamortized deferred financing costs of $20.3 million and $22.8 million at September 30, 2020 and December 31, 2019, respectively. The carrying value of Non-recourse mortgages, net includes unamortized deferred financing costs of $0.4 million and $0.6 million at September 30, 2020 and December 31, 2019, respectively.
(b)The carrying value of Senior Unsecured Notes, net includes unamortized discount of $18.5 million and $20.5 million at September 30, 2020 and December 31, 2019, respectively. The carrying value of Non-recourse mortgages, net includes unamortized discount of $4.8 million and $6.2 million at September 30, 2020 and December 31, 2019, respectively.
(c)We determined the estimated fair value of the Senior Unsecured Notes using observed market prices in an open market with limited trading volume.
(d)We determined the estimated fair value of our non-recourse mortgage loans using a discounted cash flow model that estimates the present value of the future loan payments by discounting such payments at current estimated market interest rates. The estimated market interest rates consider interest rate risk and the value of the underlying collateral, which includes quality of the collateral, the credit quality of the tenant/obligor, and the time until maturity.
Schedule of fair value impairment charges using unobservable inputs nonrecurring basis
The following tables present information about assets for which we recorded an impairment charge and that were measured at fair value on a non-recurring basis (in thousands):
 Three Months Ended September 30, 2020Three Months Ended September 30, 2019
 Fair Value
Measurements
Total Impairment
Charges
Fair Value
Measurements
Total Impairment
Charges
Impairment Charges
Net investment in direct financing leases$— $— $24,418 $25,781 
$— $25,781 

Nine Months Ended September 30, 2020Nine Months Ended September 30, 2019
Fair Value
Measurements
Total Impairment
Charges
Fair Value
Measurements
Total Impairment
Charges
Impairment Charges
Equity investments in the Managed Programs
$37,396 $47,112 $— $— 
Land, buildings and improvements and intangibles
12,148 19,420 — — 
Net investment in direct financing leases— — 24,418 25,781 
$66,532 $25,781